胸腔镜治疗肺癌58例临床分析  

The clinical efficacy of treating lung cancer by the thoracoscope surgery:Clinical analysis of 58 cases

作　　者：唐安球[1] 覃海航[1] 吴强[1] 廖世锋[1] 覃江华[1] 

机构地区：[1]广西壮族自治区河池市第三人民医院胸外科,广西河池547000

出　　处：《中国现代医生》2013年第6期26-27,共2页China Modern Doctor

摘　　要：目的探究胸腔镜手术(VATS)治疗肺癌的临床疗效。方法将以传统开胸手术治疗的患者作为对照组,以胸腔镜手术治疗的患者作为治疗组,并对两组患者的临床疗效和并发症及不良反应进行统计分析;结果采用胸腔镜手术治疗肺癌的临床有效率为87.93%,显著优于传统开胸手术(P<0.01),其手术后出血量、引流置管时间、术后住院时间显著优于传统开胸手术(P<0.05),且并发症和不良反应的总发生率较低,为(5.17%)。结论胸腔镜手术治疗肺癌的临床疗效显著,可有效减少患者的死亡率,为今后临床使用该法治疗肺癌提供一定的理论依据。Objective To explore the clinical efficacy of treating lung cancer by thoracoscope surgery （VATS）. Meth- ods Put the patients treated by the traditional open thoracic surgical as control group and put the patients treated by thoracoscope surgery as treatment group, then analyzed statistically the clinical curative effect and complications and adverse reaction of patients of the two groups. Results The total effective rate of clinical treatment of lung cancer by the thoracoscope surgery was 87.93%, significantly better than traditional open thoracic surgery（P 〈 0.01 ）, the amount of bleeding after the operation drainage catheter time postoperative hospitalization time was significantly better than traditional open thoracic surgery（P 〈 0.05）, and the total incidence rate of complications and adverse reaction just was 5.17%. Conclusion The curative effect of treating lung cancer by the thoracoscope surgery is distinct, which can effec- tively reduce the mortality of patients and provide certain theory basis for the future treatment of lung cancer by the method in the clinical.

关 键 词：胸腔镜手术 肺癌 

分 类 号：R734.2[医药卫生—肿瘤]